- Megatas S 50 mg Tablet effectively alleviates symptoms of Overactive Bladder (OAB).
- This formulation helps reduce urinary urgency and frequency.
- Patients can experience improved bladder control with Megatas S 50 mg Tablet.
- The combination of Mirabegron and Solifenacin in Megatas S 50 mg Tablet works to relax bladder muscles.
- Megatas S 50 mg Tablet is suitable for individuals who have not responded well to other OAB treatments.
- This medication can enhance the quality of life for those suffering from OAB.
- Megatas S 50 mg Tablet may help prevent involuntary bladder contractions.
- Using Megatas S 50 mg Tablet can lead to fewer nighttime trips to the bathroom.
- Patients may find that Megatas S 50 mg Tablet reduces the risk of urinary incontinence.
- Megatas S 50 mg Tablet supports better hydration by managing urinary output.
- This therapy can be part of a comprehensive treatment plan for OAB.
- Megatas S 50 mg Tablet is designed for long-term management of bladder symptoms.
Megatas S 50 mg Tablet - Strip of 10
Prescription Required
Compositions : Solifenacin 5mg + Mirabegron 50mg
₹483.93
(Incl. GST)
MRP :
(Incl. GST)
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Intas Pharmaceuticals Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Megatas S 50 mg Tablet is a specialized pharmaceutical formulation designed to address the symptoms associated with Overactive Bladder (OAB). This medication combines two active ingredients, Mirabegron and Solifenacin, which work synergistically to provide relief from the discomfort and urgency that often accompany OAB. The primary purpose of Megatas S 50 mg Tablet is to enhance bladder control and improve the quality of life for individuals suffering from this condition. As a combination therapy, Megatas S 50 mg Tablet falls under the therapeutic category of urinary tract medications, specifically targeting bladder muscle relaxation and reducing involuntary contractions. The key composition of Megatas S 50 mg Tablet includes 50 mg of Mirabegron, a beta-3 adrenergic agonist, and 5 mg of Solifenacin, an antimuscarinic agent. Together, these components effectively manage the symptoms of OAB by relaxing the bladder muscles and decreasing the frequency of urination. Patients using Megatas S 50 mg Tablet can expect a significant reduction in urgency and frequency of urination, allowing for a more comfortable daily experience. This medication is particularly beneficial for those who have not found adequate relief from other treatments. Overall, Megatas S 50 mg Tablet represents a modern approach to managing OAB symptoms, providing patients with a reliable option for improving their bladder health and overall well-being.
Product Details
Uses & Benefits
How Megatas S 50 mg Tablet works
Megatas S 50 mg Tablet operates through a dual mechanism involving its active ingredients. Mirabegron stimulates beta-3 adrenergic receptors in the bladder, promoting muscle relaxation, while Solifenacin inhibits muscarinic receptors, further aiding in bladder control.
Megatas S 50 mg Tablet operates through a dual mechanism involving its active ingredients. Mirabegron stimulates beta-3 adrenergic receptors in the bladder, promoting muscle relaxation, while Solifenacin inhibits muscarinic receptors, further aiding in bladder control.
- Mirabegron enhances bladder capacity by relaxing detrusor muscles.
- Solifenacin reduces involuntary contractions of the bladder.
- Together, they decrease the sensation of urgency associated with OAB.
- Megatas S 50 mg Tablet helps maintain a balanced urinary function.
- This combination therapy allows for improved patient compliance due to its efficacy.
- The synergistic action of both components leads to significant symptom relief.
How to use Megatas S 50 mg Tablet
- The recommended dosage of Megatas S 50 mg Tablet is one tablet daily.
- Take Megatas S 50 mg Tablet with or without food as directed by your healthcare provider.
- Swallow the tablet whole; do not crush or chew it.
- Consistency in timing is important; take Megatas S 50 mg Tablet at the same time each day.
- Duration of treatment with Megatas S 50 mg Tablet should be determined by your doctor based on your response.
- Do not exceed the prescribed dose of Megatas S 50 mg Tablet without consulting your healthcare professional.
- If you miss a dose, take it as soon as you remember unless it's almost time for your next dose.
- Consult your doctor if you have any questions about how to use Megatas S 50 mg Tablet.
Lifestyle Advice
- Maintain a healthy diet rich in fiber to help manage constipation associated with Megatas S 50 mg Tablet.
- Stay hydrated but monitor fluid intake to avoid excessive urination.
- Avoid caffeine and alcohol as they may exacerbate OAB symptoms while using Megatas S 50 mg Tablet.
- Incorporate pelvic floor exercises into your routine to strengthen bladder control.
- Establish a regular bathroom schedule to help train your bladder while on Megatas S 50 mg Tablet.
Safety Advice
Side Effects
Side Effects
- Common side effects of Megatas S 50 mg Tablet include dry mouth and constipation.
- Some patients may experience headaches while taking Megatas S 50 mg Tablet.
- Blurred vision can occur as a side effect of Megatas S 50 mg Tablet.
- High blood pressure has been reported in some users of Megatas S 50 mg Tablet.
- Nasal inflammation (nasopharyngitis) may also be experienced by some patients.
- If you notice any severe side effects such as urinary retention, seek medical attention immediately.
- Consult your healthcare provider if side effects persist or worsen while using Megatas S 50 mg Tablet.
Precautions and Warnings
Precautions & Warnings
- Do not use Megatas S 50 mg Tablet if you are allergic to any of its components.
- Patients with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet without medical advice.
- Alcohol consumption should be limited while taking Megatas S 50 mg Tablet due to potential interactions.
- Pregnant or breastfeeding women should consult their doctor before using Megatas S 50 mg Tablet.
- Driving or operating heavy machinery may be affected; caution is advised when using Megatas S 50 mg Tablet.
- Inform your doctor about all medications you are taking to avoid drug interactions with Megatas S 50 mg Tablet.
- If you experience any unusual symptoms while taking Megatas S 50 mg Tablet, contact your healthcare provider promptly.
FAQs
1. What is Megatas S 50 mg Tablet used for?
Megatas S 50 mg Tablet is primarily used to treat symptoms associated with Overactive Bladder (OAB), such as frequent urination and urgency.
2. How should I take Megatas S 50 mg Tablet?
It is recommended to take one Megatas S 50 mg Tablet daily, either with or without food, as directed by your healthcare provider.
3. What are the common side effects of Megatas S 50 mg Tablet?
Common side effects include dry mouth, constipation, headaches, and blurred vision. Most side effects are mild and may resolve over time.
4. Can I drink alcohol while taking Megatas S 50 mg Tablet?
It is advisable to limit alcohol consumption while taking Megatas S 50 mg Tablet due to potential interactions that may affect its efficacy.
5. Who should avoid using Megatas S 50 mg Tablet?
Individuals with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet unless advised by their healthcare provider.
6. What should I do if I miss a dose of Megatas S 50 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not double up on doses.
7. Is it safe to use Megatas S 50 mg Tablet during pregnancy?
Pregnant women should consult their doctor before using Megatas S 50 mg Tablet to ensure safety for both mother and baby.
Megatas S 50 mg Tablet is primarily used to treat symptoms associated with Overactive Bladder (OAB), such as frequent urination and urgency.
2. How should I take Megatas S 50 mg Tablet?
It is recommended to take one Megatas S 50 mg Tablet daily, either with or without food, as directed by your healthcare provider.
3. What are the common side effects of Megatas S 50 mg Tablet?
Common side effects include dry mouth, constipation, headaches, and blurred vision. Most side effects are mild and may resolve over time.
4. Can I drink alcohol while taking Megatas S 50 mg Tablet?
It is advisable to limit alcohol consumption while taking Megatas S 50 mg Tablet due to potential interactions that may affect its efficacy.
5. Who should avoid using Megatas S 50 mg Tablet?
Individuals with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet unless advised by their healthcare provider.
6. What should I do if I miss a dose of Megatas S 50 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not double up on doses.
7. Is it safe to use Megatas S 50 mg Tablet during pregnancy?
Pregnant women should consult their doctor before using Megatas S 50 mg Tablet to ensure safety for both mother and baby.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
More Information
| SKU | 141022 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Megatas S 50 mg Tablet is a specialized pharmaceutical formulation designed to address the symptoms associated with Overactive Bladder (OAB). This medication combines two active ingredients, Mirabegron and Solifenacin, which work synergistically to provide relief from the discomfort and urgency that often accompany OAB. The primary purpose of Megatas S 50 mg Tablet is to enhance bladder control and improve the quality of life for individuals suffering from this condition. As a combination therapy, Megatas S 50 mg Tablet falls under the therapeutic category of urinary tract medications, specifically targeting bladder muscle relaxation and reducing involuntary contractions. The key composition of Megatas S 50 mg Tablet includes 50 mg of Mirabegron, a beta-3 adrenergic agonist, and 5 mg of Solifenacin, an antimuscarinic agent. Together, these components effectively manage the symptoms of OAB by relaxing the bladder muscles and decreasing the frequency of urination. Patients using Megatas S 50 mg Tablet can expect a significant reduction in urgency and frequency of urination, allowing for a more comfortable daily experience. This medication is particularly beneficial for those who have not found adequate relief from other treatments. Overall, Megatas S 50 mg Tablet represents a modern approach to managing OAB symptoms, providing patients with a reliable option for improving their bladder health and overall well-being.
Uses & Benefits
- Megatas S 50 mg Tablet effectively alleviates symptoms of Overactive Bladder (OAB).
- This formulation helps reduce urinary urgency and frequency.
- Patients can experience improved bladder control with Megatas S 50 mg Tablet.
- The combination of Mirabegron and Solifenacin in Megatas S 50 mg Tablet works to relax bladder muscles.
- Megatas S 50 mg Tablet is suitable for individuals who have not responded well to other OAB treatments.
- This medication can enhance the quality of life for those suffering from OAB.
- Megatas S 50 mg Tablet may help prevent involuntary bladder contractions.
- Using Megatas S 50 mg Tablet can lead to fewer nighttime trips to the bathroom.
- Patients may find that Megatas S 50 mg Tablet reduces the risk of urinary incontinence.
- Megatas S 50 mg Tablet supports better hydration by managing urinary output.
- This therapy can be part of a comprehensive treatment plan for OAB.
- Megatas S 50 mg Tablet is designed for long-term management of bladder symptoms.
How Megatas S 50 mg Tablet works
Megatas S 50 mg Tablet operates through a dual mechanism involving its active ingredients. Mirabegron stimulates beta-3 adrenergic receptors in the bladder, promoting muscle relaxation, while Solifenacin inhibits muscarinic receptors, further aiding in bladder control.
Megatas S 50 mg Tablet operates through a dual mechanism involving its active ingredients. Mirabegron stimulates beta-3 adrenergic receptors in the bladder, promoting muscle relaxation, while Solifenacin inhibits muscarinic receptors, further aiding in bladder control.
- Mirabegron enhances bladder capacity by relaxing detrusor muscles.
- Solifenacin reduces involuntary contractions of the bladder.
- Together, they decrease the sensation of urgency associated with OAB.
- Megatas S 50 mg Tablet helps maintain a balanced urinary function.
- This combination therapy allows for improved patient compliance due to its efficacy.
- The synergistic action of both components leads to significant symptom relief.
How to use Megatas S 50 mg Tablet
- The recommended dosage of Megatas S 50 mg Tablet is one tablet daily.
- Take Megatas S 50 mg Tablet with or without food as directed by your healthcare provider.
- Swallow the tablet whole; do not crush or chew it.
- Consistency in timing is important; take Megatas S 50 mg Tablet at the same time each day.
- Duration of treatment with Megatas S 50 mg Tablet should be determined by your doctor based on your response.
- Do not exceed the prescribed dose of Megatas S 50 mg Tablet without consulting your healthcare professional.
- If you miss a dose, take it as soon as you remember unless it's almost time for your next dose.
- Consult your doctor if you have any questions about how to use Megatas S 50 mg Tablet.
Lifestyle Advice
- Maintain a healthy diet rich in fiber to help manage constipation associated with Megatas S 50 mg Tablet.
- Stay hydrated but monitor fluid intake to avoid excessive urination.
- Avoid caffeine and alcohol as they may exacerbate OAB symptoms while using Megatas S 50 mg Tablet.
- Incorporate pelvic floor exercises into your routine to strengthen bladder control.
- Establish a regular bathroom schedule to help train your bladder while on Megatas S 50 mg Tablet.
Side Effects
Side Effects
- Common side effects of Megatas S 50 mg Tablet include dry mouth and constipation.
- Some patients may experience headaches while taking Megatas S 50 mg Tablet.
- Blurred vision can occur as a side effect of Megatas S 50 mg Tablet.
- High blood pressure has been reported in some users of Megatas S 50 mg Tablet.
- Nasal inflammation (nasopharyngitis) may also be experienced by some patients.
- If you notice any severe side effects such as urinary retention, seek medical attention immediately.
- Consult your healthcare provider if side effects persist or worsen while using Megatas S 50 mg Tablet.
Precautions and Warnings
Precautions & Warnings
- Do not use Megatas S 50 mg Tablet if you are allergic to any of its components.
- Patients with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet without medical advice.
- Alcohol consumption should be limited while taking Megatas S 50 mg Tablet due to potential interactions.
- Pregnant or breastfeeding women should consult their doctor before using Megatas S 50 mg Tablet.
- Driving or operating heavy machinery may be affected; caution is advised when using Megatas S 50 mg Tablet.
- Inform your doctor about all medications you are taking to avoid drug interactions with Megatas S 50 mg Tablet.
- If you experience any unusual symptoms while taking Megatas S 50 mg Tablet, contact your healthcare provider promptly.
1. What is Megatas S 50 mg Tablet used for?
Megatas S 50 mg Tablet is primarily used to treat symptoms associated with Overactive Bladder (OAB), such as frequent urination and urgency.
2. How should I take Megatas S 50 mg Tablet?
It is recommended to take one Megatas S 50 mg Tablet daily, either with or without food, as directed by your healthcare provider.
3. What are the common side effects of Megatas S 50 mg Tablet?
Common side effects include dry mouth, constipation, headaches, and blurred vision. Most side effects are mild and may resolve over time.
4. Can I drink alcohol while taking Megatas S 50 mg Tablet?
It is advisable to limit alcohol consumption while taking Megatas S 50 mg Tablet due to potential interactions that may affect its efficacy.
5. Who should avoid using Megatas S 50 mg Tablet?
Individuals with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet unless advised by their healthcare provider.
6. What should I do if I miss a dose of Megatas S 50 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not double up on doses.
7. Is it safe to use Megatas S 50 mg Tablet during pregnancy?
Pregnant women should consult their doctor before using Megatas S 50 mg Tablet to ensure safety for both mother and baby.
Megatas S 50 mg Tablet is primarily used to treat symptoms associated with Overactive Bladder (OAB), such as frequent urination and urgency.
2. How should I take Megatas S 50 mg Tablet?
It is recommended to take one Megatas S 50 mg Tablet daily, either with or without food, as directed by your healthcare provider.
3. What are the common side effects of Megatas S 50 mg Tablet?
Common side effects include dry mouth, constipation, headaches, and blurred vision. Most side effects are mild and may resolve over time.
4. Can I drink alcohol while taking Megatas S 50 mg Tablet?
It is advisable to limit alcohol consumption while taking Megatas S 50 mg Tablet due to potential interactions that may affect its efficacy.
5. Who should avoid using Megatas S 50 mg Tablet?
Individuals with severe kidney or liver impairment should avoid using Megatas S 50 mg Tablet unless advised by their healthcare provider.
6. What should I do if I miss a dose of Megatas S 50 mg Tablet?
If you miss a dose, take it as soon as you remember unless it's close to the time for your next dose. Do not double up on doses.
7. Is it safe to use Megatas S 50 mg Tablet during pregnancy?
Pregnant women should consult their doctor before using Megatas S 50 mg Tablet to ensure safety for both mother and baby.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
| SKU | 141022 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Intas Pharmaceuticals Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account